ReproCELL
Business Services · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Kdx Shin-yokohama 381 bldg 9f, Yokohama,...Phone Number
+81 454753887Website
www.reprocell.comRevenue
$15.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About ReproCELL
Founded in 2003, ReproCELL operates as a stem cell research company, offering stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, and feeder cells; and 3D cell culture, labware, and drug discovery assays. The company also provides stem cell services, such as target cell isolation, iPSC reprogramming, and cell differentiation, as well as iPSC expansion, characterization, and banking services; and predictive drug discovery services in the areas of cardiac, vascular, respiratory, gastrointestinal, ADME/DMPK, skin/skin model, genitourinary, comparative pharmacology, and other assays. The company is headquartered in Yokohama, Japan.Explore more
ReproCELL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ReproCELL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ReproCELL recently announced quarterly report
Click to see if ReproCELL had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ReproCELL launches new products
Check out if ReproCELL is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ReproCELL
Check if ReproCELL has recently received funding, and reach out quickly before it becomes old news!
ReproCELL, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ReproCELL has new funding data
Recommended Actions
Find VP level buyers at ReproCELL
Find 3 more new buyers
Company Profile Activity
Activity Insights
ReproCELL is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ReproCELL is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ReproCELL.
ReproCELL Tech Stack
A closer look at the technologies used by ReproCELL
Most Recent Scoops
Pain Point
Project
, according to a front-line source in product development, is planning to remediate challenges related to improving time to market. The organization is currently evaluating various vendors.
Pain Point, Product Development, Product Launch, Product Management
Project
, according to a front-line source in product development, began leveraging ChatGPT within the last three months or less. ReproCELL is leveraging this solution for data enrichment and hygiene.
Product Development, Product Management
Award
Award, Business Development, Search, Medical Research, Clinical Operations, Operations
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Manufacturing Operations
Event
ReproCELL News & Media
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services BELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service...REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools
BELTSVILLE, Md., Jan. 28, 2026 /PRNewswire/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA,...REPROCELL USA Receives Funding from the Maryland Stem Cell Research Fund (MSCRF)
REPROCELL USA is proud to announce it has received funding from Maryland Stem Cell Commission through its Maryland Stem Cell Research Fund (MSCRF) via the Manufacturing Assistance Grant Program, as a part of the July 2025 grant cycle. This grant will support the development of a Contract...REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)
REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF's January 2024 grant cycle. These two grants will help us produce Master Cell Banks (MCB) for cell therapy and enhance our capacity to produce therapeutic cell...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ReproCELL
Sign Up For FreeTo access detailed company insights
Founded in 2003, ReproCELL operates as a stem cell research company, offering stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated ind... Read More
